Literature DB >> 27895024

The Role of Calcium/Calmodulin-Dependent Protein Kinase II Activation in Hypertrophic Cardiomyopathy.

Jil C Tardiff1.   

Abstract

Entities:  

Keywords:  Editorials; calcium regulation; calcium/calmodulin-dependent protein kinase II; cardiac remodeling; genetics; human; hypertrophic cardiomyopathy

Mesh：

Substances：

Year:  2016        PMID： 27895024      PMCID： PMC5358792          DOI： 10.1161/CIRCULATIONAHA.116.025455

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

2.  Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history.

Authors:  S Frank; E Braunwald
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

3.  Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.

Authors:  Raffaele Coppini; Cecilia Ferrantini; Lina Yao; Peidong Fan; Martina Del Lungo; Francesca Stillitano; Laura Sartiani; Benedetta Tosi; Silvia Suffredini; Chiara Tesi; Magdi Yacoub; Iacopo Olivotto; Luiz Belardinelli; Corrado Poggesi; Elisabetta Cerbai; Alessandro Mugelli
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

4.  Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers.

Authors:  Carolyn Y Ho; Allison L Cirino; Neal K Lakdawala; John Groarke; Anne Marie Valente; Christopher Semsarian; Steven D Colan; E John Orav
Journal:  Heart       Date:  2016-09-02       Impact factor: 5.994

5.  The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.

Authors:  Johannes Backs; Thea Backs; Stefan Neef; Michael M Kreusser; Lorenz H Lehmann; David M Patrick; Chad E Grueter; Xiaoxia Qi; James A Richardson; Joseph A Hill; Hugo A Katus; Rhonda Bassel-Duby; Lars S Maier; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 6.  A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations.

Authors:  Luís R Lopes; M Shafiqur Rahman; Perry M Elliott
Journal:  Heart       Date:  2013-05-14       Impact factor: 5.994

7.  Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.

Authors:  P Spirito; B J Maron; F Chiarella; P Bellotti; R Tramarin; M Pozzoli; C Vecchio
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

8.  Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.

Authors:  Pia J Guinto; Todd E Haim; Candice C Dowell-Martino; Nathaniel Sibinga; Jil C Tardiff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

Review 9.  The role of calmodulin kinase II in myocardial physiology and disease.

Authors:  Luis F Couchonnal; Mark E Anderson
Journal:  Physiology (Bethesda)       Date:  2008-06

10.  Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.

Authors:  Zhong Jian; Huilan Han; Tieqiao Zhang; Jose Puglisi; Leighton T Izu; John A Shaw; Ekama Onofiok; Jeffery R Erickson; Yi-Je Chen; Balazs Horvath; Rafael Shimkunas; Wenwu Xiao; Yuanpei Li; Tingrui Pan; James Chan; Tamas Banyasz; Jil C Tardiff; Nipavan Chiamvimonvat; Donald M Bers; Kit S Lam; Ye Chen-Izu
Journal:  Sci Signal       Date:  2014-03-18       Impact factor: 8.192
View more
  4 in total

Review 1.  Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective.

Authors:  Ares Pasipoularides
Journal:  J Mol Cell Cardiol       Date:  2018-11-10       Impact factor: 5.000

2.  An ImmunoSignature test distinguishes Trypanosoma cruzi, hepatitis B, hepatitis C and West Nile virus seropositivity among asymptomatic blood donors.

Authors:  Michael Rowe; Jonathan Melnick; Robert Gerwien; Joseph B Legutki; Jessica Pfeilsticker; Theodore M Tarasow; Kathryn F Sykes
Journal:  PLoS Negl Trop Dis       Date:  2017-09-05

3.  Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.

Authors:  Alexander J Sparrow; Kolja Sievert; Suketu Patel; Yu-Fen Chang; Connor N Broyles; Frances A Brook; Hugh Watkins; Michael A Geeves; Charles S Redwood; Paul Robinson; Matthew J Daniels
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

4.  Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling.

Authors:  Paul Robinson; Xing Liu; Alexander Sparrow; Suketu Patel; Yin-Hua Zhang; Barbara Casadei; Hugh Watkins; Charles Redwood
Journal:  J Biol Chem       Date:  2018-05-14       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.